Skip to main content
main-content

CME articles

The present review focuses on biological disease-modifying antirheumatic drugs (DMARDs) and targeted synthetic DMARDs regarding similarities and possible drug-specific advantages in the treatment of rheumatoid arthritis.
​​​​​​​Credit available: 1 (one) AMA PRA Category 1 Credit™
Valid until: August 2018

    A practical approach focusing on outlining recommendations for identifying and treating comorbid depression among rheumatoid arthritis patients, to be implemented within a rheumatology clinic setting.​​​​​​​
    ​​​​​​​Credit available: 1 (one) AMA PRA Category 1 Credit™
    Valid until: August 2018

      The authors provide a practical update on the main aspects of prevention and treatment of cardiovascular comorbidities in rheumatoid arthritis, focusing on atherosclerotic cardiovascular disease.
      Credit available: 1 (one) AMA PRA Category 1 Credit™
      Valid until: July 2018

        image credits